Royal DSM, the global Life Sciences and Materials Sciences company, announced it has signed agreements to acquire a 19% equity interest in Yantai Andre Pectin Co. Ltd. (Andre Pectin), a China-based producer of texturing ingredients.
In addition, the parties have agreed that DSM has option rights to increase its stake in Andre Pectin to a majority stake at a later stage. The agreements are subject to customary approvals and certain closing conditions, including the approval of the selling party’s shareholders. Closing is expected in Q3 2013.
